human bladder cancer cell lines t24 (p53-mutant) Search Results


t 24  (ATCC)
98
ATCC t 24
Effect of <t>p53</t> silencing on cytotoxicity of FrA. a , b Western blotting analysis of p53 expression in RT112 cells treated with FrA for 48 h ( a ) or transfected with p53 siRNA versus cells transfected with scrambled siRNA ( b ). c Viability of transfected cells treated with FrA or Cis for 48 h. Cell viability was analyzed by flow cytometry analysis using annexin-V-FITC/PI double staining. Viable cells appearing in the lower left quadrant were quantified using the Cell Quest Pro software. d , e Effect of pifithrin-α (Pif-α)–an inhibitor of p53 activity–on the cytotoxic activity of FrA and Cis in nontransfected RT112 cells. Cells were pretreated with 40 μM of Pif-α for 30 min and then cotreated with FrA ( d ) or Cis ( e ) for 48 h. Cell viability was determined using MTT-assay
T 24, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/pmc05286817-43-17-23?v=ATCC
Average 98 stars, based on 1 article reviews
t 24 - by Bioz Stars, 2026-08
98/100 stars
  Buy from Supplier

90
BioResource International Inc human bladder cancer cell lines t24 (p53-mutant)
Effect of <t>p53</t> silencing on cytotoxicity of FrA. a , b Western blotting analysis of p53 expression in RT112 cells treated with FrA for 48 h ( a ) or transfected with p53 siRNA versus cells transfected with scrambled siRNA ( b ). c Viability of transfected cells treated with FrA or Cis for 48 h. Cell viability was analyzed by flow cytometry analysis using annexin-V-FITC/PI double staining. Viable cells appearing in the lower left quadrant were quantified using the Cell Quest Pro software. d , e Effect of pifithrin-α (Pif-α)–an inhibitor of p53 activity–on the cytotoxic activity of FrA and Cis in nontransfected RT112 cells. Cells were pretreated with 40 μM of Pif-α for 30 min and then cotreated with FrA ( d ) or Cis ( e ) for 48 h. Cell viability was determined using MTT-assay
Human Bladder Cancer Cell Lines T24 (P53 Mutant), supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/pm28498480-24-0-15?v=BioResource+International+Inc
Average 90 stars, based on 1 article reviews
human bladder cancer cell lines t24 (p53-mutant) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BioResource International Inc human bladder cancer cell lines tsgh-8301 (wild-type p53)
Effect of <t>p53</t> silencing on cytotoxicity of FrA. a , b Western blotting analysis of p53 expression in RT112 cells treated with FrA for 48 h ( a ) or transfected with p53 siRNA versus cells transfected with scrambled siRNA ( b ). c Viability of transfected cells treated with FrA or Cis for 48 h. Cell viability was analyzed by flow cytometry analysis using annexin-V-FITC/PI double staining. Viable cells appearing in the lower left quadrant were quantified using the Cell Quest Pro software. d , e Effect of pifithrin-α (Pif-α)–an inhibitor of p53 activity–on the cytotoxic activity of FrA and Cis in nontransfected RT112 cells. Cells were pretreated with 40 μM of Pif-α for 30 min and then cotreated with FrA ( d ) or Cis ( e ) for 48 h. Cell viability was determined using MTT-assay
Human Bladder Cancer Cell Lines Tsgh 8301 (Wild Type P53), supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/pm28498480-24-8-15?v=BioResource+International+Inc
Average 90 stars, based on 1 article reviews
human bladder cancer cell lines tsgh-8301 (wild-type p53) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

93
Biotium cd7(t3-3a1)
Effect of <t>p53</t> silencing on cytotoxicity of FrA. a , b Western blotting analysis of p53 expression in RT112 cells treated with FrA for 48 h ( a ) or transfected with p53 siRNA versus cells transfected with scrambled siRNA ( b ). c Viability of transfected cells treated with FrA or Cis for 48 h. Cell viability was analyzed by flow cytometry analysis using annexin-V-FITC/PI double staining. Viable cells appearing in the lower left quadrant were quantified using the Cell Quest Pro software. d , e Effect of pifithrin-α (Pif-α)–an inhibitor of p53 activity–on the cytotoxic activity of FrA and Cis in nontransfected RT112 cells. Cells were pretreated with 40 μM of Pif-α for 30 min and then cotreated with FrA ( d ) or Cis ( e ) for 48 h. Cell viability was determined using MTT-assay
Cd7(t3 3a1), supplied by Biotium, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/custom%40bnc040978-100%40us07759479?v=Biotium
Average 93 stars, based on 1 article reviews
cd7(t3-3a1) - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

99
ATCC mutant p53
Information about cell lines
Mutant P53, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/pmc00024283-124-298-307?v=ATCC
Average 99 stars, based on 1 article reviews
mutant p53 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

96
ATCC caption a7
Information about cell lines
Caption A7, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/pmc00024283-124-23-37?v=ATCC
Average 96 stars, based on 1 article reviews
caption a7 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

95
ATCC source bhk atcc ψ2 retroviral packaging atcc pa317 retroviral packaging atcc pa shd pa317 packaging control virus lxshd
Information about cell lines
Source Bhk Atcc ψ2 Retroviral Packaging Atcc Pa317 Retroviral Packaging Atcc Pa Shd Pa317 Packaging Control Virus Lxshd, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/pmc00024283-124-35-37?v=ATCC
Average 95 stars, based on 1 article reviews
source bhk atcc ψ2 retroviral packaging atcc pa317 retroviral packaging atcc pa shd pa317 packaging control virus lxshd - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

Image Search Results


Effect of p53 silencing on cytotoxicity of FrA. a , b Western blotting analysis of p53 expression in RT112 cells treated with FrA for 48 h ( a ) or transfected with p53 siRNA versus cells transfected with scrambled siRNA ( b ). c Viability of transfected cells treated with FrA or Cis for 48 h. Cell viability was analyzed by flow cytometry analysis using annexin-V-FITC/PI double staining. Viable cells appearing in the lower left quadrant were quantified using the Cell Quest Pro software. d , e Effect of pifithrin-α (Pif-α)–an inhibitor of p53 activity–on the cytotoxic activity of FrA and Cis in nontransfected RT112 cells. Cells were pretreated with 40 μM of Pif-α for 30 min and then cotreated with FrA ( d ) or Cis ( e ) for 48 h. Cell viability was determined using MTT-assay

Journal: BMC Cancer

Article Title: The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells

doi: 10.1186/s12885-017-3085-z

Figure Lengend Snippet: Effect of p53 silencing on cytotoxicity of FrA. a , b Western blotting analysis of p53 expression in RT112 cells treated with FrA for 48 h ( a ) or transfected with p53 siRNA versus cells transfected with scrambled siRNA ( b ). c Viability of transfected cells treated with FrA or Cis for 48 h. Cell viability was analyzed by flow cytometry analysis using annexin-V-FITC/PI double staining. Viable cells appearing in the lower left quadrant were quantified using the Cell Quest Pro software. d , e Effect of pifithrin-α (Pif-α)–an inhibitor of p53 activity–on the cytotoxic activity of FrA and Cis in nontransfected RT112 cells. Cells were pretreated with 40 μM of Pif-α for 30 min and then cotreated with FrA ( d ) or Cis ( e ) for 48 h. Cell viability was determined using MTT-assay

Article Snippet: The human urothelial cancer cell lines RT4 (p53 wild type), HT-1197 (p53 wild type), TCC-SUP (mutant p53), T-24 (mutant p53), were purchased from ATCC (Manassas, VA, USA) [ ].

Techniques: Western Blot, Expressing, Transfection, Flow Cytometry, Double Staining, Software, Activity Assay, MTT Assay

Information about cell lines

Journal:

Article Title: The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments

doi:

Figure Lengend Snippet: Information about cell lines

Article Snippet: Cells were obtained from subconfluent cultures, and colonies were scored 14–21 days later ( 20 ). table ft1 table-wrap mode="anchored" t5 Table 1 caption a7 Designate Parental line Related characteristics and transgene expression Reference or source BHK ATCC Ψ2 Retroviral packaging ATCC PA317 Retroviral packaging ATCC PA/SHD PA317 Packaging control virus LXSHD This study PA/mR1 PA317 Packaging SHD/mR1 * virus This study SC2 L60 R2 is in excess as compared to R1 McClarty et al . ( 6 ) SC2/SHD SC2 his D † This study SC2/mR1 SC2 mR1, his D † This study CIRAS-1 10T½ T24 H- ras Egan et al . ( 25 ) C1/SHD CIRAS-1 his D † , T24 H- ras This study C1/mR1 CIRAS-1 mR1 * , his D † , T24 H- ras This study C1/mR2 CIRAS-1 mR2 * , T24 H- ras Fan et al . ( 20 ) C1/mR2/SHD C1/mR2 his D † , mR2 * , T24 H- ras This study C1/mR2/mR1 C1/mR2 mR1, his D † , mR2 * , T24 H- ras This study C1/mR2a/SHD C1/mR2a ‡ his D † , mR2 * , T24 H- ras This study C1/mR2a/mR1 C1/mR2a ‡ mR1 * , his D † , mR2 * , T24 H- ras This study ras-3 (or R-3) 10T½ T24 H- ras Taylor et al . ( 26 ) ras-3/SHD ras-3 his D † , T24 H- ras This study ras-3/mR1 ras-3 mR1 * , his D † , T24 H- ras This study RMP-6 10T½ T24 H- ras , c- myc , mutant p53 Taylor et al . ( 26 ) RMP/SHD RMP-6 his D † , T24 H- ras , c- myc , mutant p53 This study RMP/mR1 RMP-6 mR1 * , his D † , T24 H- ras , c- myc , mutant p53 This study Colo 320HSR Human colon carcinoma ATCC Colo/SHD Colo 320HSR his D † This study Colo/mR1 Colo 320HSR mR1 * , his D † This study NIH 3T3 ATCC N/ ras NIH3T3 T24 H- ras , neo † This study N/ ras &ASR1 NIH3T3 R1 antisense, T24 H- ras , neo † This study Open in a separate window ATCC, American Type Culture Collection.

Techniques: Expressing, Mutagenesis

Information about cell lines

Journal:

Article Title: The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments

doi:

Figure Lengend Snippet: Information about cell lines

Article Snippet: Cells were obtained from subconfluent cultures, and colonies were scored 14–21 days later ( 20 ). table ft1 table-wrap mode="anchored" t5 Table 1 caption a7 Designate Parental line Related characteristics and transgene expression Reference or source BHK ATCC Ψ2 Retroviral packaging ATCC PA317 Retroviral packaging ATCC PA/SHD PA317 Packaging control virus LXSHD This study PA/mR1 PA317 Packaging SHD/mR1 * virus This study SC2 L60 R2 is in excess as compared to R1 McClarty et al . ( 6 ) SC2/SHD SC2 his D † This study SC2/mR1 SC2 mR1, his D † This study CIRAS-1 10T½ T24 H- ras Egan et al . ( 25 ) C1/SHD CIRAS-1 his D † , T24 H- ras This study C1/mR1 CIRAS-1 mR1 * , his D † , T24 H- ras This study C1/mR2 CIRAS-1 mR2 * , T24 H- ras Fan et al . ( 20 ) C1/mR2/SHD C1/mR2 his D † , mR2 * , T24 H- ras This study C1/mR2/mR1 C1/mR2 mR1, his D † , mR2 * , T24 H- ras This study C1/mR2a/SHD C1/mR2a ‡ his D † , mR2 * , T24 H- ras This study C1/mR2a/mR1 C1/mR2a ‡ mR1 * , his D † , mR2 * , T24 H- ras This study ras-3 (or R-3) 10T½ T24 H- ras Taylor et al . ( 26 ) ras-3/SHD ras-3 his D † , T24 H- ras This study ras-3/mR1 ras-3 mR1 * , his D † , T24 H- ras This study RMP-6 10T½ T24 H- ras , c- myc , mutant p53 Taylor et al . ( 26 ) RMP/SHD RMP-6 his D † , T24 H- ras , c- myc , mutant p53 This study RMP/mR1 RMP-6 mR1 * , his D † , T24 H- ras , c- myc , mutant p53 This study Colo 320HSR Human colon carcinoma ATCC Colo/SHD Colo 320HSR his D † This study Colo/mR1 Colo 320HSR mR1 * , his D † This study NIH 3T3 ATCC N/ ras NIH3T3 T24 H- ras , neo † This study N/ ras &ASR1 NIH3T3 R1 antisense, T24 H- ras , neo † This study Open in a separate window ATCC, American Type Culture Collection.

Techniques: Expressing, Mutagenesis

Analysis of Myc-tagged R1 expression from pSHD/mR1 transiently transfected BHK cells by the indirect immunofluorescence assay (A), and from the stable retroviral packaging cell line PA/mR1 by radioimmunoprecipitation (B). Anti-Myc epitope antibody 9E10 was used for both assays.

Journal:

Article Title: The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments

doi:

Figure Lengend Snippet: Analysis of Myc-tagged R1 expression from pSHD/mR1 transiently transfected BHK cells by the indirect immunofluorescence assay (A), and from the stable retroviral packaging cell line PA/mR1 by radioimmunoprecipitation (B). Anti-Myc epitope antibody 9E10 was used for both assays.

Article Snippet: Cells were obtained from subconfluent cultures, and colonies were scored 14–21 days later ( 20 ). table ft1 table-wrap mode="anchored" t5 Table 1 caption a7 Designate Parental line Related characteristics and transgene expression Reference or source BHK ATCC Ψ2 Retroviral packaging ATCC PA317 Retroviral packaging ATCC PA/SHD PA317 Packaging control virus LXSHD This study PA/mR1 PA317 Packaging SHD/mR1 * virus This study SC2 L60 R2 is in excess as compared to R1 McClarty et al . ( 6 ) SC2/SHD SC2 his D † This study SC2/mR1 SC2 mR1, his D † This study CIRAS-1 10T½ T24 H- ras Egan et al . ( 25 ) C1/SHD CIRAS-1 his D † , T24 H- ras This study C1/mR1 CIRAS-1 mR1 * , his D † , T24 H- ras This study C1/mR2 CIRAS-1 mR2 * , T24 H- ras Fan et al . ( 20 ) C1/mR2/SHD C1/mR2 his D † , mR2 * , T24 H- ras This study C1/mR2/mR1 C1/mR2 mR1, his D † , mR2 * , T24 H- ras This study C1/mR2a/SHD C1/mR2a ‡ his D † , mR2 * , T24 H- ras This study C1/mR2a/mR1 C1/mR2a ‡ mR1 * , his D † , mR2 * , T24 H- ras This study ras-3 (or R-3) 10T½ T24 H- ras Taylor et al . ( 26 ) ras-3/SHD ras-3 his D † , T24 H- ras This study ras-3/mR1 ras-3 mR1 * , his D † , T24 H- ras This study RMP-6 10T½ T24 H- ras , c- myc , mutant p53 Taylor et al . ( 26 ) RMP/SHD RMP-6 his D † , T24 H- ras , c- myc , mutant p53 This study RMP/mR1 RMP-6 mR1 * , his D † , T24 H- ras , c- myc , mutant p53 This study Colo 320HSR Human colon carcinoma ATCC Colo/SHD Colo 320HSR his D † This study Colo/mR1 Colo 320HSR mR1 * , his D † This study NIH 3T3 ATCC N/ ras NIH3T3 T24 H- ras , neo † This study N/ ras &ASR1 NIH3T3 R1 antisense, T24 H- ras , neo † This study Open in a separate window ATCC, American Type Culture Collection.

Techniques: Expressing, Transfection, Immunofluorescence